These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 21596100)

  • 21. Oxidative stress in relation to diet and physical activity among premenopausal women.
    Anderson C; Milne GL; Sandler DP; Nichols HB
    Br J Nutr; 2016 Oct; 116(8):1416-1424. PubMed ID: 27725001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay.
    Morales CR; Terry ES; Zackert WE; Montine TJ; Morrow JD
    Clin Chim Acta; 2001 Dec; 314(1-2):93-9. PubMed ID: 11718683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. F2-isoprostanes as markers of oxidative stress in vivo: an overview.
    Milne GL; Musiek ES; Morrow JD
    Biomarkers; 2005 Nov; 10 Suppl 1():S10-23. PubMed ID: 16298907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E-ring isoprostane augments cholinergic neurotransmission in bovine trachealis via FP prostanoid receptors.
    Paredes C; Tazzeo T; Janssen LJ
    Am J Respir Cell Mol Biol; 2007 Dec; 37(6):739-47. PubMed ID: 17630320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. F2-isoprostanes are not just markers of oxidative stress.
    Comporti M; Signorini C; Arezzini B; Vecchio D; Monaco B; Gardi C
    Free Radic Biol Med; 2008 Feb; 44(3):247-56. PubMed ID: 17997380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. F
    Proudfoot JM; Murrey MW; McLean S; Greenland EL; Barden AE; Croft KD; Galano JM; Durand T; Mori TA; Pixley FJ
    Free Radic Biol Med; 2018 Oct; 126():142-152. PubMed ID: 30096434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients.
    Montuschi P; Corradi M; Ciabattoni G; Nightingale J; Kharitonov SA; Barnes PJ
    Am J Respir Crit Care Med; 1999 Jul; 160(1):216-20. PubMed ID: 10390403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formation of trans-epoxy fatty acids correlates with formation of isoprostanes and could serve as biomarker of oxidative stress.
    Rund KM; Heylmann D; Seiwert N; Wecklein S; Oger C; Galano JM; Durand T; Chen R; Gueler F; Fahrer J; Bornhorst J; Schebb NH
    Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106334. PubMed ID: 31009766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular pharmacology and physiology of the isoprostanes.
    Cracowski JL; Durand T
    Fundam Clin Pharmacol; 2006 Oct; 20(5):417-27. PubMed ID: 16968413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoprostanes: an emerging role in vascular physiology and disease?
    Cracowski JL
    Chem Phys Lipids; 2004 Mar; 128(1-2):75-83. PubMed ID: 15037154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acid.
    Gao L; Yin H; Milne GL; Porter NA; Morrow JD
    J Biol Chem; 2006 May; 281(20):14092-9. PubMed ID: 16569632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary fats and F
    Da Silva MS; Bilodeau JF; Julien P; Rudkowska I
    Crit Rev Food Sci Nutr; 2017 Dec; 57(18):3929-3941. PubMed ID: 27438347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of endothelial thromboxane A2 in the vasoconstrictor response induced by 15-E2t-isoprostane in isolated human umbilical vein.
    Daray FM; Colombo JR; Kibrik JR; Errasti AE; Pelorosso FG; Nowak W; Cracowski JL; Rothlin RP
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Aug; 373(5):367-75. PubMed ID: 16738877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of formation of D2/E2-isoprostanes and F2-isoprostanes in vitro and in vivo--effects of oxygen tension and glutathione.
    Morrow JD; Roberts LJ; Daniel VC; Awad JA; Mirochnitchenko O; Swift LL; Burk RF
    Arch Biochem Biophys; 1998 May; 353(1):160-71. PubMed ID: 9578611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Isoprostanes: a putative key role in vascular diseases].
    Cracowski JL
    Rev Med Interne; 2004 Jun; 25(6):459-63. PubMed ID: 15158317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite.
    Hou X; Roberts LJ; Taber DF; Morrow JD; Kanai K; Gobeil F; Beauchamp MH; Bernier SG; Lepage G; Varma DR; Chemtob S
    Am J Physiol Regul Integr Comp Physiol; 2001 Aug; 281(2):R391-400. PubMed ID: 11448840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pulmonary biology of isoprostanes.
    Janssen LJ
    Chem Phys Lipids; 2004 Mar; 128(1-2):101-16. PubMed ID: 15037156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential applications of lipid peroxidation products - F
    De Las Heras-Gómez I; Medina S; Casas-Pina T; Marín-Soler L; Tomás A; Martínez-Hernández P; Oger C; Galano JM; Durand T; Jimeno L; Llorente S; Lozoya E; Ferreres F; Gil-Izquierdo Á
    Free Radic Biol Med; 2017 Mar; 104():178-184. PubMed ID: 28089724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cyclopentenone (A2/J2) isoprostanes--unique, highly reactive products of arachidonate peroxidation.
    Milne GL; Musiek ES; Morrow JD
    Antioxid Redox Signal; 2005; 7(1-2):210-20. PubMed ID: 15650409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. F₂-isoprostane formation, measurement and interpretation: the role of exercise.
    Nikolaidis MG; Kyparos A; Vrabas IS
    Prog Lipid Res; 2011 Jan; 50(1):89-103. PubMed ID: 20951733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.